Document reference

2021/2601(DEA)  
Inclusion of the new psychoactive substances methyl 3,3-dimethyl-2-{[1-(pent-4-en-1-yl)-1H-indazole-3-carbonyl]amino}butanoate (MDMB-4en-PINACA) and methyl 2-{[1-(4-fluorobutyl)-1H-indole-3-carbonyl]amino}-3,3-dimethylbutanoate (4F-MDMB-BICA) in the definition of ‘drug’  
Basic information  

2021/2601(DEA)

DEA - Delegated acts procedure


Subject
4.20.03 Drug addiction, alcoholism, smoking
7.30.30.04 Action to combat drugs and drug-trafficking

Status

Procedure completed - delegated act enters into force

 

Please go to Documentation gateway for any follow-up documents.: Please go to Documentation gateway for any follow-up documents. 
Key players  
Key events  
12/03/2021
Non-legislative basic document published
C(2021)01570
12/03/2021
Initial period for examining delegated act 2 month(s)
24/03/2021
Committee referral announced in Parliament
22/05/2021
Delegated act not objected by Parliament
Technical information  
Procedure reference
2021/2601(DEA)
Procedure type
DEA - Delegated acts procedure
Procedure subtype
Examination of delegated act
Stage reached in procedure
Procedure completed - delegated act enters into force
Committee dossier
LIBE/9/05608
Documentation gateway